Subcutaneous IgG in the Myositis Spectrum Disorders

Area of Science:

• Immunology
• Neurology
• Rheumatology

Background:

• Subcutaneous immunoglobulin (SCIg) is increasingly used for neurological disorders.
• Its application in idiopathic inflammatory myopathies (IIM) like polymyositis and dermatomyositis is emerging.
• The precise role of SCIg in rare myositis disorders remains under-investigated.

Purpose of the Study:

• To review the use of subcutaneous immunoglobulin in myositis spectrum disorders.
• To evaluate SCIg efficacy in idiopathic inflammatory myopathies and related conditions.

Main Methods:

• Retrospective case series analysis.
• Review of patient data on SCIg treatment for myositis.

Main Results:

• SCIg administration in various myositis conditions.
• Exploration of SCIg use in overlap, cancer-associated, and pregnancy-related myositis.

Conclusions:

• Subcutaneous immunoglobulin represents a potential therapeutic option for myositis spectrum disorders.
• Further investigation is warranted to establish optimal use and efficacy.